| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | — | +50.8% |
| R&D Expense | $10.2M | — | +0.1% |
| SG&A Expense | $4.2M | — | +10.3% |
| Operating Income | -$13.1M | — | +0.2% |
| Income Tax | $0 | — | — |
| Net Income | -$18.3M | — | -47.4% |
| EPS (Basic) | -$0.32 | — | +48.4% |
| EPS (Diluted) | -$0.32 | — | +48.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $99.2M | -9.4% | +101.1% |
| Current Assets | $102.2M | -10.4% | +97.8% |
| Total Assets | $105.5M | -10.5% | +68.0% |
| Current Liabilities | $16.6M | +7.2% | +158.1% |
| Total Liabilities | $74.6M | +6.3% | +565.6% |
| Stockholders' Equity | $30.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.0M | — | +23.1% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $57K | — | +137.7% |
| Free Cash Flow | -$11.0M | — | +24.6% |
| -40.1% |